Leaflet PROHANCE 0.5mmol / ml solution for injection in pre-filled syringe


Indicated for: diagnostic imaging contrast enhancement

Route of administration: injectable

Substance: gadoteridol (contrast agent)

ATC: V08CA04 (Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media)

Gadoteridol is a contrast agent used in magnetic resonance imaging (MRI) to enhance the visualization of internal structures, including the brain, spine, and other organs. It is a gadolinium-based contrast agent.

This medication is administered intravenously and is used for diagnosing neurological, vascular, or oncological conditions.

Adverse reactions may include nausea, dizziness, headache, or injection site reactions. In rare cases, severe allergic reactions or nephrogenic systemic fibrosis may occur in patients with kidney impairment.

It is important to discuss your medical history, especially kidney conditions, with your doctor before receiving gadoteridol.

General data about PROHANCE 0.5mmol / ml

  • Substance: gadoteridol
  • Date of last drug list: 01-04-2023
  • Commercial code: W66184008
  • Concentration: 0.5mmol / ml
  • Pharmaceutical form: solution for injection in pre-filled syringe
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BRACCO IMAGING S.P.A. - ITALIA
  • Holder: BRACCO IMAGING S.P.A. - ITALIA
  • Number: 11934/2019/08
  • Shelf life: 3 years; After first opening the bottle. - it is used immediately

Pharmaceutical forms available for gadoteridol